Abstract:Objective Using the liquid chromatography-tandem mass spectrometry(LC-MS/MS)to determine the plasma level of Lyso-GL3 in patients with Fabry disease and to analyze the clinical application of the method.Methods Thirty-nine patients with a genetic diagnosis of Fabry disease were included,and plasma levels of Lyso-GL3 were measured by LC-MS/MS analysis,and detailed clinical information of the patients was obtained including:α-galactosidase A activity,genetic variants,quantification of urine protein,mean arterial pressure,and estimation of glomerular filtration rate,and the differences in the levels of Lyso-GL3 in different clinical phenotypes and genotypes were statistically analyzed,as well as the association with clinical indicators.Results Lyso-GL3 showed good linearity within 0.7856-400 ng/mL(r=0.9992).Further analysis of 39 Fabry disease patients diagnosed in Ruijin Hospital,Shanghai Jiao Tong University School of Medicine showed a median Lyso-GL3 concentration of 23.6 ng/mL(4.3-92.9 ng/mL);Lyso-GL3 levels were significantly higher in patients with both the frameshift and the splicing mutations,as well as in patients with the nonsense mutations,than in patients with the missense mutations(median value 119.7 ng/mL vs.11.9 ng/mL,P=0.006,and medi-an value 97.0 ng/mL vs.11.9 ng/mL,P=0.015,respectively).Whereas,association analysis revealed that Ly-so-GL3 was not significantly associated with urinary protein,mean arterial pressure and estimated glomerular fil-tration rate.Conclusions The using of LC-MS/MS to quantify plasma Lyso-GL showed significant differences in Lyso-GL3 concentrations between classical and atypical phenotypes,suggesting that plasma Lyso-GL3 may help with clinical phenotypes.However,Lyso-GL3 levels is found to be overlapped between genotypes.No significant linear correlation was found between Lyso-GL3 and renal clinical indicators,suggesting the urgent need in finding a more accurate tool to assess renal involvement and prognosis in patients with Fabry disease.

High-throughput Detection of Common Sequence Variations of Fabry Disease in Taiwan Using DNA Mass Spectrometry.

AB101. Improvement in the Sensitivity of Newborn Screening for Fabry Disease among Females Through the Use of a High-Throughput and Cost-Effective Method, DNA Mass Spectrometry

The use of high resolution melting analysis to detect Fabry mutations in heterozygous females via dry bloodspots.

Improvement in the sensitivity of newborn screening for Fabry disease among females through the use of a high-throughput and cost-effective method, DNA mass spectrometry

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population

Functional and Biological Studies of Alpha-Galactosidase A Variants with Uncertain Significance from Newborn Screening in Taiwan

Detecting Multiple Lysosomal Storage Diseases by Tandem Mass Spectrometry--a National Newborn Screening Program in Taiwan.

Rapid Detection of Twenty-Nine Common Chinese Glucose-6-phosphate Dehydrogenase Variants Using a Matrix-Assisted Laser Desorption/ionization-Time of Flight Mass Spectrometry Assay on Dried Blood Spots.

Enzyme Assay and Clinical Assessment in Subjects with a Chinese Hotspot Late-Onset Fabry Mutation (IVS4 + 919G→A)

Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China

MGB Probe Assay for Rapid Detection of Mtdna11778 Mutation in the Chinese LHON Patients by Real-Time PCR

PCR-SSCP: A Sensitive Screening Strategy for Anderson Fabry Disease

Prenatal Diagnosis of Glycogen Storage Disease Ia by Screening for Hot Spot Mutations in Combination with the 1176 Nucleotide Polymorphism Linkage Analysis

Endomyocardial Biopsies in Patients with Left Ventricular Hypertrophy and a Common Chinese Later-Onset Fabry Mutation (IVS4 + 919G > A)

Single Cell Four-Plex Nested Fluorescent PCR for Hemophilia A Genetic Diagnosis and Gender Determination

Novel technique for rapid detection of α-globin gene mutations and deletions

Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.

Using Liquid Chromatography-Tandem Mass Spectrometry in Detecting Plasma Lyso-GL3 Levels in Patients with Fabry Disease and the Association Analysis of Phenotype-Genotype of the Disease

Multiple SNPs Detection Based on Lateral Flow Assay for Phenylketonuria Diagnostic

Value of α-galactosidase A activity assay in diagnosis and screening of Fabry's disease